biomarker discovery

NEW YORK (GenomeWeb News) – The University of Manchester's Institute of Cancer Sciences said today that it will lead an international consortium that will use €6 million ($7.9 million) in funding to develop genetic biomarkers to identify patients who are at risk of developing long-term side effec

NEW YORK (GenomeWeb News) – The European Union plans to fund new research seeking to establish the clinical utility of epigenetic biomarkers for blood-based diseases under its Blueprint consortium program, a €30 million ($39.8 million) effort focused on advancing hematopoietic biomarkers.

NEW YORK (GenomeWeb News) – Ten institutes at the National Institutes of Health plan to provide $17.5 million in funding next year to support a network of as many as 14 consortia that will pursue clinica

NEW YORK (GenomeWeb News) – A consortium led by the University of Texas Health Science Center at San Antonio has received a five-year award for up to $45 million from the US Department of Defense and US Department of Veterans Affairs to use next-generation sequencing and mass spectrometry to cond

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Berg and the US Department of Defense today announced an agreement to discover biomarkers for prostate cancer and to develop more effective treatments for the disease.

NEW YORK (GenomeWeb News) – A 14-member consortium of European companies and academic partners have been awarded €6 million ($7.7 million) from the EU to use genomics technologies to develop biomarker-driven personalized vaccines for glioma patients.

NEW YORK (GenomeWeb News) – Genewiz and the John Theurer Cancer Center at Hackensack University Medical Center today announced a collaboration for the discovery of ovarian cancer biomarkers.

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute has struck a collaborative research agreement with Ventana Medical Systems to study new biomarkers for use in treating pancreatic cancer, Ventana said today.

NEW YORK (GenomeWeb News) – Myriad Genetics today said that its Myriad RBM subsidiary has formed a research collaboration with DaVita Labs to discover protein-based biomarkers that could be used to benefit dialysis patients.

NEW YORK (GenomeWeb News) – UK cancer biomarker firm Abcodia today announced a collaboration with the Austrian Institute of Technology to validate biomarkers for the early detection of lung and colorectal cancers.